AI + Real-World Data: What the Next Five Years Look Like for Pharma
In the final episode of Real-World Data After Dark season 2, host Daniel Chancellor is joined by Norstella’s Kris Kaneta, Chief Product & Innovation Officer, and Ted Search, Chief Real-World Data & Analytics Officer, to explore what’s next for real-world data, artificial intelligence, and healthcare analytics. Looking beyond today’s AI capabilities, the conversation examines how […]
Stop Flying Blind. Start Targeting with Greater Precision.
NorstellaLinQ explores how integrated real-world data and AI-powered analytics help pharmaceutical commercial teams identify high-value patients, understand prescriber behavior and uncover emerging market opportunities. By connecting claims, structured and unstructured EHR data, laboratory results, social determinants of health (SDOH) and mortality data into a single clinically validated asset, NorstellaLinQ delivers the insights needed to improve […]
Unstructured EHR Data Unmatched Clinical Insights
Norstella transforms unstructured physician notes into longitudinal, analytics-ready data that reveals insights traditional healthcare datasets miss. By combining AI, data curation, and clinical expertise, Norstella helps pharmaceutical teams better understand patient journeys, identify hard-to-find patient populations, optimize HCP engagement and make smarter commercial decisions. Powered by NorstellaLinQ, these insights connect real-time EHR data, claims, lab […]
Find the Right Patient Before the Competition Does
Traditional commercial targeting relies on historical claims and broad provider segments. NorstellaLinQ changes the equation by combining AI-curated clinical data, real-world patient journeys, predictive analytics, and near real-time clinical signals to identify more patients, engage providers earlier, predict what’s next, and coordinate commercial teams around the highest-value opportunities. In this infographic, find out how NorstellaLinQ can help […]
Finding the Right Patients Faster: AI and Real-World Data in Practice
Artificial intelligence is reshaping how life sciences organizations generate evidence, identify patients and make critical decisions—but only when it’s built on trusted, explainable data. In this episode of Real-World Data After Dark, Daniel Chancellor is joined by Norstella’s Kris Kaneta and Ted Search to discuss where AI can create the greatest impact across the pharmaceutical […]
Busting Real-World Data and AI Myths
Artificial intelligence is transforming how life sciences organizations unlock the full value of real-world data—but success depends on more than AI alone. In this episode of Real-World Data After Dark, Daniel Chancellor is joined by Kris Kaneta, Chief Product & Innovation Officer at Norstella, and Ted Search, Chief Real-World Data & Analytics Officer at Norstella, […]
How AI is Changing Clinical Development
AI is no longer a peripheral tool in drug development. It is reshaping how trials are designed, run, and completed, and the pace of change is accelerating. In this episode of the Drug Discovery World Podcast, Suzanne Caruso, President and General Manager of Clinical, Regulatory and Strategic Intelligence at Norstella, speaks with host Bruno Quinney […]
Trustworthy and Novel AI in Clinical Trial Planning
This pharmaphorum podcast explores how AI is transforming drug development and commercialization, with Norstella Chief Product Officer Kris Kaneta discussing the growing role of clinical AI powered by robust patient-level data. Kaneta explains how AI can move beyond administrative efficiency to deliver real strategic recommendations for clinical trials, commercialization and decision-making across the product lifecycle. […]
Why an AI-Native Biotech Chose Norstella
Drug development has made huge scientific progress over the last decade. The way we run clinical development has changed far less. Timelines are still long. Costs are still high. And most of the risk is decided before a trial even begins—we just don’t treat it that way. Teams are making critical decisions about study design, […]
From Fuel to Firepower: How Real-World Data and AI are Accelerating Pharma
Real-world data (RWD) and Artificial Intelligence (AI) are evolving fast, and with the integration of unstructured data, large language models (LLMs), and multimodal data sources, the next generation of RWD promises deeper, more holistic patient insights than ever before. By combining clinical notes, patient-reported outcomes, and social determinants of health, next-gen RWD can deliver a […]
